← Back to Search

Wound Closure Methods for Scar Appearance

N/A

Waitlist Available

Led By Daniel Eisen, MD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older

Patient scheduled for cutaneous surgical procedure on the head, neck, trunk, or extremities with predicted purse-string closure

Must not have

Under 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to compare two different methods of closing wounds to see which one results in better-looking scars and fewer complications. They will close half of the wound with one method and the other half with another

Who is the study for?

This trial is for individuals with scars who are undergoing surgery that requires wound closure. The study will compare two different stitching techniques to see which results in better-looking scars and fewer complications.

What is being tested?

The study tests intra-dermal versus transcutaneous purse-string closures on wounds. Each patient's wound is split; one half gets the intra-dermal method, the other half gets the transcutaneous method. Scar appearance and any complications are assessed after three months.

What are the potential side effects?

Potential side effects may include differences in scar appearance, discomfort at the suture site, infection, or other common post-surgical complications related to wound healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am scheduled for skin surgery with a specific type of closure.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Observer Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)

Secondary study objectives

Complications or Adverse Events from Treatment

Patient Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)

Width of Scar as measured using Trace-to-Tape Method

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Intra-dermal purse-string closure on Side BExperimental Treatment2 Interventions

For all participants, one wound side half will be labeled as A and the other side as B. Side B will be closed with a intra-dermal purse-string closure, and Side A will be closed with a transcutaneous purse-string closure.

Group II: Intra-dermal purse-string closure on Side AExperimental Treatment2 Interventions

For all participants, one wound side half will be labeled as A and the other side as B. Side A will be closed with a intra-dermal purse-string closure, and Side B will be closed with a transcutaneous purse-string closure.

0 / 3Eligibility criteria met